All Stories

  1. New Drugs for Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat and Omecamtiv Mecarbil

    Article • ABC Heart Failure & Cardiomyopathy, January 2022, Sociedade Brasileira de Cardiologia

    Dr Carlos H. Del Carlo

  2. O Tratamento Medicamentoso Habitual é Suficiente para Manter o Controle da Frequência Cardíaca nos Pacientes com Insuficiência Cardíaca?

    Article • Arquivos Brasileiros de Cardiologia, December 2020, Sociedade Brasileira de Cardiologia

    Dr Carlos H. Del Carlo

  3. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

    Article • The American Journal of Medicine, December 2019, Elsevier

    Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  4. Rule-out myocardial infarction in the high-sensitivity cardiac troponin era

    Article • International Journal of Cardiology, August 2019, Elsevier

    Dr Carlos H. Del Carlo

  5. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

    Article • American Heart Journal, July 2019, Elsevier

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  6. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation

    Article • JAMA Cardiology, June 2019, American Medical Association (AMA)

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  7. Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry

    Article • Clinical Cardiology, April 2019, Wiley

    Dr. Kenji Sadamatsu, Dr Carlos H. Del Carlo

  8. Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

    Article • Journal of the American Heart Association, February 2019, Wolters Kluwer Health

    Professor Zhi-Cheng JING, Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Filipa Costa, Dr Carlos H. Del Carlo

  9. Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan　― Insights From GARFIELD-AF ―

    Article • Circulation Journal, December 2018, Japanese Circulation Society

    Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  10. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

    Article • Indian Heart Journal, November 2018, Elsevier

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Filipa Costa, Diego Chemello, Dr Carlos H. Del Carlo

  11. Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry

    Article • Acta Cardiologica, October 2018, Taylor & Francis

    Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  12. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

    Article • PLOS One, January 2018, PLOS

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  13. Infection in Patients with Decompensated Heart Failure: In-Hospital Mortality and Outcome

    Article • Arquivos Brasileiros de Cardiologia, January 2018, Sociedade Brasileira de Cardiologia

    Dr Carlos H. Del Carlo

  14. Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry

    Article • European Heart Journal, December 2017, Oxford University Press (OUP)

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  15. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation

    Article • BMJ Open, December 2017, BMJ

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  16. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries

    Article • American Heart Journal, December 2017, Elsevier

    Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  17. Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry

    Article • BMJ Open, March 2017, BMJ

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  18. OUP accepted manuscript

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, January 2017, Oxford University Press (OUP)

    Keith Fox, Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  19. Evolving quality standards for large-scale registries: the GARFIELD-AF experience

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, November 2016, Oxford University Press (OUP)

    Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  20. Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry

    Article • International Journal of Cardiology, November 2016, Elsevier

    Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  21. Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

    Article • PLOS One, October 2016, PLOS

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  22. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

    Article • Heart, September 2016, BMJ

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  23. Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

    Article • European Heart Journal, June 2016, European Society of Cardiology

    Prof jean-pierre L bassand, Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Dr Carlos H. Del Carlo

  24. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists

    Article • British Journal of Haematology, April 2016, Wiley

    Professor David Montes, Dr Helena DOMINGUEZ VALL-LAMORA, Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Filipa Costa, Diego Chemello, Dr Carlos H. Del Carlo

  25. Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation

    Article • Circulation Cardiovascular Quality and Outcomes, February 2015, Wolters Kluwer Health

    Dr Helena DOMINGUEZ VALL-LAMORA, Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Filipa Costa, Diego Chemello, Massimo Volpe, Dr Carlos H. Del Carlo

  26. Rare Association: Chagas' Disease and Hypertrophic Cardiomyopathy

    Article • Annals of Noninvasive Electrocardiology, November 2014, Wiley

    Dr Carlos H. Del Carlo

  27. Mortality rates are going down in clinical use of inotropics. Temporal trends for prognosis in acute decompensated heart failure (1992/1999–2005/ 2006)

    Article • International Journal of Cardiology, August 2014, Elsevier

    Dr Carlos H. Del Carlo

  28. Temporal Variation in the Prognosis and Treatment of Advanced Heart Failure - Before and After 2000

    Article • Arquivos Brasileiros de Cardiologia, January 2014, Sociedade Brasileira de Cardiologia

    Dr Carlos H. Del Carlo

  29. Optimized Treatment and Heart Rate Reduction in Chronic Heart Failure

    Article • Arquivos Brasileiros de Cardiologia, January 2013, Sociedade Brasileira de Cardiologia

    Dr Carlos H. Del Carlo

  30. Role of BNP Levels on the Prognosis of Decompensated Advanced Heart Failure

    Article • Arquivos Brasileiros de Cardiologia, January 2013, Sociedade Brasileira de Cardiologia

    Dr Carlos H. Del Carlo

  31. Relação entre depressão, nível de BNP e comprometimento ventricular na insuficiência cardíaca

    Article • Arquivos Brasileiros de Cardiologia, December 2010, FapUNIFESP (SciELO)

    Dr Carlos H. Del Carlo

  32. Microneurografia e pletismografia de oclusão venosa na insuficiência cardíaca: correlação com prognóstico

    Article • Arquivos Brasileiros de Cardiologia, January 2009, FapUNIFESP (SciELO)

    Dr Carlos H. Del Carlo

  33. Por que os portadores de cardiomiopatia chagásica têm pior evolução que os não-chagásicos?

    Article • Arquivos Brasileiros de Cardiologia, December 2008, FapUNIFESP (SciELO)

    Dr Carlos H. Del Carlo

  34. Re-hospitalizações e morte por insuficiência cardíaca: índices ainda alarmantes

    Article • Arquivos Brasileiros de Cardiologia, November 2008, FapUNIFESP (SciELO)

    Dr Carlos H. Del Carlo

  35. Anemia in Advanced Heart Failure Is Due to Iron Deficiency and Malnutrition and It Is Associated with Worse Prognosis

    Article • Journal of Cardiac Failure, August 2006, Elsevier

    Dr Carlos H. Del Carlo

  36. Fast up Titration of Carvedilol in Heart Failure Is Safe and Allow Discharging Patients with Full Dosage and the Identification of Those with Worse Prognosis

    Article • Journal of Cardiac Failure, August 2006, Elsevier

    Dr Carlos H. Del Carlo

  37. O nível sérico de NT-proBNP é um preditor prognóstico em pacientes com insuficiência cardíaca avançada

    Article • Arquivos Brasileiros de Cardiologia, August 2006, FapUNIFESP (SciELO)

    Dr Carlos H. Del Carlo

  38. Principais características clínicas de pacientes que sobrevivem 24 meses ou mais após uma hospitalização devido a descompensação cardíaca

    Article • Arquivos Brasileiros de Cardiologia, February 2005, FapUNIFESP (SciELO)

    Dr Carlos H. Del Carlo

  39. NT-ProBNP serum levels are an excellent prognostic predictor in patients with advanced heart failure hospitalized for compensation

    Article • Journal of Cardiac Failure, August 2004, Elsevier

    Dr Carlos H. Del Carlo

  40. Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure

    Article • Journal of Cardiac Failure, February 2004, Elsevier

    Dr Carlos H. Del Carlo

  41. Cardiac troponins in congestive heart failure

    Article • American Heart Journal, October 1999, Elsevier

    Dr Carlos H. Del Carlo

  42. Clinical Characteristics and Long-term Outcomes of Patients With Diastolic Heart Failure

    Article • Journal of the American College of Cardiology, February 1998, Elsevier

    Dr Carlos H. Del Carlo